{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-039525","form_type":"8-K","ticker":"RNXT","cik":"0001574094","company_name":"RenovoRx, Inc.","filed_at":"2023-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.587262+00:00","generated_at":"2026-06-08T20:40:19.051297+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"RenovoRx gets Nasdaq extension to Feb 19, 2024 for $2.5M equity compliance","bullets":["Nasdaq granted extension to February 19, 2024 to meet $2.5M stockholders' equity requirement (Rule 5550(b)(2)).","Company must evidence full compliance by deadline; failure triggers delist determination.","Delist determination can be stayed by request for hearing before Nasdaq Hearings Panel.","No assurance of compliance; risk of delisting if not met."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-039525","json":"https://secwatch.observer/filing/0001493152-23-039525.json","markdown":"https://secwatch.observer/filing/0001493152-23-039525.md","text":"https://secwatch.observer/filing/0001493152-23-039525.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1574094/000149315223039525/0001493152-23-039525-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1574094/000149315223039525/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T20:40:19.051297+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}